share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

輝瑞 | 4：持股變動聲明-董事 Quincey James
美股sec公告 ·  04/26 13:28
Moomoo AI 已提取核心訊息
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
在最近的一筆交易中，輝瑞公司 [PFE] 的舉報人昆西·詹姆斯於2024年4月25日執行了一筆股票交易。該交易的細節，包括所涉及的股票數量和交易價格，尚未披露。也沒有提供股份的性質和昆西·詹姆斯在訴訟後持有的股票數量。這些信息對於投資者了解對輝瑞股票投資的潛在影響至關重要。
在最近的一筆交易中，輝瑞公司 [PFE] 的舉報人昆西·詹姆斯於2024年4月25日執行了一筆股票交易。該交易的細節，包括所涉及的股票數量和交易價格，尚未披露。也沒有提供股份的性質和昆西·詹姆斯在訴訟後持有的股票數量。這些信息對於投資者了解對輝瑞股票投資的潛在影響至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息